Profound Medical
PROF
31 hedge funds and large institutions have $75.5M invested in Profound Medical in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 3 closing their positions.
402% more call options, than puts
Call options by funds: $261K | Put options by funds: $52K
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.92% less ownership
Funds ownership: 36.15% → 35.23% (-0.92%)
6% less funds holding
Funds holding: 33 → 31 (-2)
24% less capital invested
Capital invested by funds: $98.7M → $75.5M (-$23.3M)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$53.1K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$42.2K |
| 3 |
RA
Royce & Associates
New York
|
+$40.4K |
| 4 |
Goldman Sachs
New York
|
+$28K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$25.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TIM
Timelo Investment Management
Aurora,
Ontario, Canada
|
-$607K |
| 2 |
ZDA
Zweig-DiMenna Associates
New York
|
-$387K |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$317K |
| 4 |
GS
Gagnon Securities
New York
|
-$238K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$117K |
PROF Hedge Fund Activity: Q3 2023 in Review
31 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q3 2023, worth a combined $75.5M — down 24% from $98.7M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PROF and 1 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 9 added.
The largest buyer was Raymond James & Associates, adding an estimated $53.1K. The largest seller was Timelo Investment Management, cutting an estimated $607K.
- 31 institutional investors held Profound Medical (PROF) as of Q3 2023, down from 33 in Q2 2023.
- Funds reported $75.5M of Profound Medical stock for Q3 2023, down 24% quarter-over-quarter.
- 1 fund opened new Profound Medical positions in Q3 2023 and 3 closed out, a net change of -2 holders.
- The largest Profound Medical buyer in Q3 2023 was Raymond James & Associates, an estimated $53.1K added.
- The largest Profound Medical seller in Q3 2023 was Timelo Investment Management, an estimated $607K sold.
Based on aggregated 13F filings for Q3 2023.